Infection Intel, IDWeek 2023 Edition
This edition of Infection Intel from Infection Control Today covers infection control and prevention company news out of IDWeek, being held in Boston, Massachusetts, from October 11 to 15, 2023.
Infection Intel is a new column for Infection Control Today® (ICT®) that will cover the latest news, including new products, updates on developments, mergers, and more from companies in the infection control and prevention field.
Infection Intel is a new column for Infection Control Today® (ICT®) that will cover the latest news, including new products, updates on developments, mergers, and more from companies in the infection control and prevention field. This edition is about the news coming from IDWeek in Boston, Massachusetts, October 11 to 15, 2023.
IDWeek is held in Boston, Massachusetts, from October 11 to 15, 2023. It is a conference “geared toward health care professionals in infectious diseases and health care epidemiology and prevention, including researchers, clinicians, quality, and patient safety practitioners, epidemiologists, pharmacists, and public health officials, including those who see HIV and pediatric patients.”
Comprehensive Strategies in Wound Care: Insights From Madhavi Ponnapalli, MD
November 22nd 2024Madhavi Ponnapalli, MD, discusses effective wound care strategies, including debridement techniques, offloading modalities, appropriate dressing selection, compression therapy, and nutritional needs for optimal healing outcomes.
The Leapfrog Group and the Positive Effect on Hospital Hand Hygiene
November 21st 2024The Leapfrog Group enhances hospital safety by publicizing hand hygiene performance, improving patient safety outcomes, and significantly reducing health care-associated infections through transparent standards and monitoring initiatives.
Managing Multimorbidity and Polypharmacy in HIV: Insights From Michelle S. Cespedes, MD, MS
November 20th 2024Michelle S. Cespedes, MD, MS, discusses the challenges of managing multimorbidity and polypharmacy in HIV treatment, emphasizing patient education, evolving guidelines, and real-world insights from the REPRIEVE study.
Longhorn Vaccines and Diagnostics to Showcase Breakthrough Vaccine Data at IDWeek 2024
November 19th 2024Longhorn Vaccines and Diagnostics revealed promising data on universal influenza vaccine LHNVD-110 and AMR sepsis vaccine LHNVD-303 at IDWeek 2024, addressing critical global health challenges.
